NLM Logo

AML91 protocol MeSH Supplementary Concept Data 2024


MeSH Supplementary
AML91 protocol
Unique ID
C478366
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C478366
Registry Number
0
Heading Mapped to
*Antineoplastic Combined Chemotherapy Protocols
Cytarabine
Daunorubicin
Deoxyadenosines
Etoposide
Frequency
1
Note
contains 2-chlorodeoxyadenosine, daunomycin, ara-c & etoposide; for treatment of childhood acute myeloid leukemia
Source
J Pediatr Hematol Oncol 2003 Sep;25(9):696-703
Date of Entry
2003/10/31
AML91 protocol Preferred
page delivered in 0.004s